Absence of rectal colonization with vancomycin-resistant enterococci among high-risk pediatric patients.
We prospectively surveyed for rectal colonization with vancomycin-resistant Enterococcus among 93 high-risk pediatric patients who were hospitalized at least 5 (median, 20) days. Fifty-two patients (56%) had enterococcal colonization; none had active infection with Enterococcus. All enterococci were vancomycin-susceptible (minimum inhibitory concentration < or =4 microg/mL). Associated exposures included recent antibiotics (50, 96%), surgical procedures (26, 58%), and immunosuppression (15, 29%).
Trabulsi
A
A
Glover
A M
AM
Reising
S F
SF
Christie
C D
CD
D000900:Anti-Bacterial Agents; D002353:Carrier State / Q000382:microbiology*; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000302:isolation & purification*; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D017053:Infection Control; D007902:Length of Stay; D008826:Microbial Sensitivity Tests; D011446:Prospective Studies; D012007:Rectum / Q000382:microbiology*; D012307:Risk Factors; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D014640:Vancomycin